118 related articles for article (PubMed ID: 15163820)
1. Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions.
Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Wagner O; Minar E
Radiology; 2004 Jun; 231(3):831-8. PubMed ID: 15163820
[TBL] [Abstract][Full Text] [Related]
2. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis.
Sabeti S; Schillinger M; Amighi J; Sherif C; Mlekusch W; Ahmadi R; Minar E
Radiology; 2004 Aug; 232(2):516-21. PubMed ID: 15286322
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and predictors of iliac angioplasty with selective stenting.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Sep; 42(3):466-75. PubMed ID: 16171589
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations.
Exner M; Schillinger M; Minar E; Mlekusch W; Sabeti S; Endler G; Raith M; Mannhalter C; Wagner O
Radiology; 2004 Jun; 231(3):839-44. PubMed ID: 15105457
[TBL] [Abstract][Full Text] [Related]
5. Chemical composition of cigarettes could be a confounding factor.
Prabhu SP
Radiology; 2005 Jan; 234(1):310; author reply 310. PubMed ID: 15618387
[No Abstract] [Full Text] [Related]
6. [Outcome of endovascular therapy of iliac, superficial femoral and popliteal arteries in 136 patients].
Jiang XJ; Zhang HM; Yang Q
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Nov; 35(11):1015-9. PubMed ID: 18269822
[TBL] [Abstract][Full Text] [Related]
7. [Doppler sonography diagnosis of restenosis after percutaneous transluminal angioplasty: sensitivity and specificity of the pedal-brachial index in relation to changes in absolute arterial blood pressure].
Radak Dj; Laps KH; Jeger KA; Ilijevski N; Vojić M
Srp Arh Celok Lek; 1998; 126(3-4):83-91. PubMed ID: 9863361
[TBL] [Abstract][Full Text] [Related]
8. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries.
Sabeti S; Mlekusch W; Amighi J; Minar E; Schillinger M
J Endovasc Ther; 2005 Feb; 12(1):6-12. PubMed ID: 15683273
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy for prophylaxis of restenosis after long-segment femoropopliteal angioplasty: pilot study.
Minar E; Pokrajac B; Ahmadi R; Maca T; Seitz W; Stümpflen A; Pötter R; Ehringer H
Radiology; 1998 Jul; 208(1):173-9. PubMed ID: 9646810
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous revascularization of femoropopliteal artery disease: PTA and PTA plus stent. Results after six years' follow-up.
Pozzi Mucelli F; Fisicaro M; Calderan L; Malacrea M; Mazzone C; Cattin L; Scardi S; Pozzi Mucelli R
Radiol Med; 2003 Apr; 105(4):339-49. PubMed ID: 12835627
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience.
Kudo T; Chandra FA; Ahn SS
J Vasc Surg; 2005 Mar; 41(3):423-35; discussion 435. PubMed ID: 15838475
[TBL] [Abstract][Full Text] [Related]
13. [Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities].
Minar E; Ahmadi RA; Ehringer H; Marosi L; Czembirek H; Konecny U
Wien Klin Wochenschr; 1986 Jan; 98(2):33-40. PubMed ID: 2938339
[TBL] [Abstract][Full Text] [Related]
14. Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts.
Schillinger M; Exner M; Mlekusch W; Haumer M; Sabeti S; Ahmadi R; Schwarzinger I; Wagner O; Minar E
J Endovasc Ther; 2003 Jun; 10(3):557-65. PubMed ID: 12932168
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
[TBL] [Abstract][Full Text] [Related]
16. What's next after optimal infrapopliteal angioplasty? Clinical and ultrasonographic results of a prospective single-center study.
Gargiulo M; Maioli F; Ceccacci T; Morselli-Labate AM; Faggioli G; Freyrie A; Giovanetti F; Testi G; Muccini N; Stella A
J Endovasc Ther; 2008 Jun; 15(3):363-9. PubMed ID: 18540709
[TBL] [Abstract][Full Text] [Related]
17. Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience.
Wolfram RM; Budinsky AC; Pokrajac B; Potter R; Minar E
Radiology; 2005 Jul; 236(1):338-42. PubMed ID: 15955854
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: a metaanalysis of randomized trials.
E Y; He N; Wang Y; Fan H
J Vasc Interv Radiol; 2008 Apr; 19(4):499-503. PubMed ID: 18375292
[TBL] [Abstract][Full Text] [Related]
19. Value of stent placement during percutaneous transluminal angioplasty of the iliac arteries.
Hassen-Khodja R; Sala F; Declemy S; Bouillanne PJ; Batt M; Staccini P
J Cardiovasc Surg (Torino); 2001 Jun; 42(3):369-74. PubMed ID: 11398035
[TBL] [Abstract][Full Text] [Related]
20. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series.
Conrad MF; Cambria RP; Stone DH; Brewster DC; Kwolek CJ; Watkins MT; Chung TK; LaMuraglia GM
J Vasc Surg; 2006 Oct; 44(4):762-9. PubMed ID: 17012001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
